Treatment of Tularemia in Pregnancy When First-Line Options Are Unavailable
Tularemia during pregnancy requires careful antibiotic selection. Evidence-based recommendations specify preferred first-line agents for pregnant patients; however, when those agents cannot be used, a distinct set of alternatives must be considered.
Clinical Scenario
Pregnant patients diagnosed with any form of tularemia. Specific agents are established as first-line therapy for this population; this protocol applies when those first-line options are not available in a given clinical setting.
Treatment Approach
When first-line therapy cannot be used in a pregnant patient, the protocol identifies a group of alternative agents spanning more than one antibiotic class. Selection among them depends on clinical criteria detailed in the full regimen — no dosages or sequencing are summarised here.
References
For pregnant women with any form of tularemia, fluoroquinolones (i.e., ciprofloxacin or levofloxacin) or gentamicin are recommended for first-line treatment.
However, moxifloxacin, ofloxacin, amikacin, tobramycin, and doxycycline can be used as alternatives to treat pregnant patients if first-line options are unavailable.
View source ↗